Objective: To determine the frequency of encrustations of ureteral stents in a tertiary care hospital of Pakistan. Patients and Methods: In this study we included 150 patients of Urology Unit of Ibn e Sina Hospital and Research Institute Multan, Pakistan in whom ureteral stents implantation was done. The study duration was April-2020 to July-2020. Patients with ureteral stents having renal stone, ureteric stone, ureteral stricture, pelviureteric junction obstruction (PUJO), trauma or malignant disease as primary pathology and duration of implantation >2 weeks to <2 years were included. Results: Mean age of patients included in this study was 46.46±12.26 years. Mean duration of stent placement was 11.96±6.01 weeks. There were 97 (64.7%) male and 53 (35.3%) female patients. There were 72 (48%) patients with renal stone disease, 32 (21.33%) patients with ureteric stone, 11 (7.33%) patients with pyeloplasty, 22 (14.67%) patients with partial nephrectomy and 13 (8.67%) patients with obstruction sec. to malignancy were included in this study. Stent encrustation was diagnosed 52 (34.67%) patients. Conclusion: After implantation, ureteral stent encrustation is still a cause for concern for urologists. Because its encrustation management may involve additional urologic procedures. In present study, stent encrustation was found in 62 (32.29%) patients. Keywords: Double-J stents, stent encrustation.
Objective: To compare the outcomes of percutaneous nephrolithotomy (PCNL) in patients with renal stones with high (≥700) versus low (<700) HU. Patients and Methods: A total of 200 patients having age 18 to 60 years, with diagnosis of unilateral renal stone disease, having stone size 2 to 4 cm in diameter on non-contrast computed tomography (NCCT) of Urology Unit of Ibn e Sina Hospital and Research Institute Multan were included. The study duration was May-2021 to July-2021. NCCT was done pre-operatively in every patient to measure Hounsfield units (HU). Post-procedural X-ray KUB was done 2 weeks after the surgical procedure to determine the stone clearance in every patient. Results: Mean age was 45.79±11.17 Years. Mean duration of disease of patients included in this study was 8.78±8.59 months. Mean stone size in patients included in this study was 3.11±0.61 cm. On comparison of stone clearance rate between the patients having high-HU versus low-HU, stone clearance was found in 61 (72.6%) patients having low HU value and in 105 (90.5%) patients having high HU value (p-value 0.001). Conclusion: HU-value ≥700 is a significant predictor of success rate of percutaneous nephrolithotomy (PCNL) in patients having renal stone disease. Keywords: Renal Stone Disease, Percutaneous nephrolithotomy, Hounsfield units (HU).
Objective: To compare the stone clearance rate in patients treated with percutaneous nephrolithotomy (PCNL) versus open surgery for the management of staghorn renal calculi. Materials and Methods: In this comparative study, a total number of 200 patients who presented in urology department of Ibn e Sina Hospital and Research Institute Multan with the diagnosis of staghorn stones were included. The study duration was October-2021 to January-2022. Group I: Patients underwent PCNL and Group II patients underwent open surgery for removal of stones. Stone clearance was two weeks of primary procedure. Results: Mean age was 45.53±10. 37 years in PCNL group versus 44.36±10.80 years in open surgery group (p-value 0.44). There were 64% male patients in PCNL group and 62% male patients in open surgery group (p-value 0.77). There were 19% patients who had bilateral stone in PCNL group and 23% in open surgery group (p-value 0.48). Complete staghorn stones were diagnosed in 70% patients in PCNL and in 73% patients in open surgery group (p-value 0.64).Stone clearance rate was 76% patients in PCNL group and 62% patients in open surgery group (p-value 0.032). Conclusion: In patients who have staghorn stones, percutaneous nephrolithotomy (PCNL) is preferable to open surgery in terms of the rate of stone clearance. Keywords: Open surgery, Staghorn stones, percutaneous nephrolithotomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.